Biotech Startups

Biotech Dispatch is an online news publication covering the biotechnology, pharmaceutical, and medical technology industries, with a focus on Australian companies and developments. It publishes articles and updates on sector news and company activities.

1 investor

A biotechnology venture fund that provides venture capital investment, loans and financing facilities, guarantees, financial brokerage, and feasibility assessment services to biotech-sector companies and projects. It operates in Iran and supports affiliated companies and knowledge-based ventures.

1 investor

Biotechnologie.de is an information portal about the German and DACH-region biotechnology and life sciences industry, publishing company profiles, startup coverage, industry data, and opinion pieces. It focuses on the development of the biotech sector in Germany and Europe.

1 investor

Ulysse Biotech develops certified biological biostimulants based on Bacillus PGPR consortiums and greenhouse hygiene products for greenhouses and field crops. Its products support root growth, nitrogen fixation, and cleaning protocols for horticultural growers in Quebec and Canada.

1 investor

BiotechTV is a media outlet producing video shows, event coverage, and news focused on the biotech and healthcare sectors, including topics like venture funding, oncology conferences, and drug development. Its programming covers industry events, CEO interviews, science spotlights, and AI news for a biotech and life sciences audience.

1 investor

Biotheranostics develops proprietary genomic assays used to support personalized disease management in oncology. The company was acquired by Hologic in February 2021.

1 investor

BioThermic Process Controls develops single-use technology for high-fidelity temperature control of precision fermentations, aimed at bioproduct manufacturers. Its systems are intended to improve first-pass quality and yield while lowering production costs across multiple industries.

1 investor

Biotitan develops nanotechnology-based surface treatments with bactericidal and virucidal properties for various environments. The company offers tailored turnkey solutions, training, and custom application services.

1 investor

Biotix develops natural, sustainable skincare ingredients derived from skin microbiome microbes, using an AI platform alongside biology experiments to identify and test ingredients for efficacy and safety. Its lead ingredient, Probix, is a microbial fermentation-derived compound intended to reinforce natural skin functions and protect against environmental irritants.

1 investor

Biotree develops metabolomics and proteomics analysis platforms and services for research institutions and pharmaceutical companies, offering laboratory testing solutions, medical devices, and cloud-based lab information systems.

1 investor

BioVana structures clinical data and biospecimen collections across African health institutions to meet international standards for biomedical research and precision medicine. The company enables biotech, pharma, and academic organizations to access diverse, well-characterized cohorts from African research institutions.

1 investor

The company develops diagnostics and diagnostic solutions for laboratory technicians, physicians, and patients, prioritizing fast and reliable testing capabilities.

1 investor

BioVentrix is a medical device company that develops less invasive therapies to treat heart failure by reconstructing the dilated left ventricle using myocardial micro-anchor implants. The company serves cardiothoracic surgeons and patients with ischemic heart failure.

1 investor

BioVeritas uses fermentation technology to convert biomass into sustainable aviation fuels and bio-based chemicals, serving the aviation fuel, food ingredients, and specialty chemicals sectors.

1 investor

BIOW develops solutions targeting the health effects of air pollution exposure, specifically investigating how bioavailable anions may support mitochondrial function and neural resilience in the context of neurodegenerative diseases and aging. The company conducts clinical research on biomarker changes and microbiome effects through advanced proteomics and metabolomics analysis.

1 investor

BioXcel Therapeutics is a biopharmaceutical company developing treatments for neuroscience conditions, including a therapy for agitation associated with bipolar disorders or schizophrenia. The company is publicly traded (Nasdaq: BTAI).

1 investor

Bioxis develops proprietary biomaterials based on chitosan and hyaluronic acid for aesthetic dermatology applications. The company creates tissue induction products designed to regenerate tissue and collagen with long-lasting effects.

1 investor

Bisc Therapeutics develops Bax inhibitor therapies designed to prevent retinal cell death and preserve vision in patients with retinal degenerative diseases such as age-related macular degeneration, glaucoma, and inherited retinal disorders. The company operates in the biotech/ophthalmology therapeutics space.

1 investor

B_Platform is a genomic analysis software that uses AI and big data to prioritize genetic variants and organize sequencing results for clinical interpretation. It supports multiple sequencing platforms and associates variants with patient phenotypes for healthcare professionals and clinical laboratories.

1 investor

Ginkgo provides autonomous laboratory systems that automate manual benchwork in biotechnology research, enabling scientists to focus on experimental design and insight rather than routine lab tasks.

1 investor

Black Swan Biotech (BSB) is a biotechnology company developing antisense oligonucleotide (ASO) therapies for Motor Neuron Disease, with a focus on Amyotrophic Lateral Sclerosis (ALS). It uses genomic research to create gene-modulating treatments targeting the genetic drivers of MND.

1 investor

Blacksmith Medicines discovers and develops small molecule inhibitors of metal-dependent enzymes for oncology and infectious disease applications. The company uses chemistry-based drug discovery approaches to address unmet medical needs.

1 investor

Blaze Bioscience is a biotechnology company developing fluorescence imaging agents that let surgeons see cancer tissue in real time during surgery. Its Tumor Paint technology and lead candidate tozuleristide (BLZ-100) aim to improve precision in cancer surgery, with current work in breast-conserving surgery.

1 investor

A biotech company focused on hemostasis and RNA therapeutics, with expertise across translational science, manufacturing, and commercialization.

1 investor